MedPath

Phenytoin Sodium

These highlights do not include all the information needed to use PHENYTOIN SODIUM INJECTION safely and effectively. See full prescribing information for PHENYTOIN SODIUM INJECTION. PHENYTOIN Sodium Injection f o r intravenous or intramuscular use Initial U.S. Approval: 1953

Approved
Approval ID

0aac9dcd-c4df-84d9-e063-6294a90a0376

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 21, 2023

Manufacturers
FDA

Medical Purchasing Solutions, LLC

DUNS: 601458529

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Phenytoin Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71872-7079
Application NumberANDA084307
Product Classification
M
Marketing Category
C73584
G
Generic Name
Phenytoin Sodium
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateNovember 21, 2023
FDA Product Classification

INGREDIENTS (5)

PROPYLENE GLYCOLInactive
Quantity: 0.4 mL in 1 mL
Code: 6DC9Q167V3
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ALCOHOLInactive
Quantity: 0.1 mL in 1 mL
Code: 3K9958V90M
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
PHENYTOIN SODIUMActive
Quantity: 50 mg in 1 mL
Code: 4182431BJH
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Phenytoin Sodium - FDA Drug Approval Details